Champions Oncology

Quarterly Financials

Values in thousands 2024-10-31 2024-07-31 2024-04-30 2024-01-31
Revenue
$13,489
$14,061
$14,001
$12,019
Gross Profit
6,417
6,989
6,751
4,170
EBITDA
1,131
1,778
621
-2,096
EBIT
732
1,329
164
-3,359
Net Income
728
1,313
-109
-2,530
Net Change In Cash
13,489
14,061
14,001
12,019
Free Cash Flow
-377
311
-1,705
-1,045
Cash
2,754
2,892
2,618
4,468
Basic Shares
14,016
14,042
13,593
13,593

Annual Financials

Values in thousands 2024-04-30 2023-04-30 2022-04-30 2021-04-30
Revenue
$50,155
$53,870
$49,109
$41,040
Gross Profit
20,754
24,338
25,477
19,566
EBITDA
-5,054
-2,069
2,234
366
EBIT
-6,921
-5,267
-179
-1,216
Net Income
-7,276
-5,335
548
362
Net Change In Cash
50,155
53,870
49,109
41,040
Cost of Revenue
1,111
4,320
-3,655
Free Cash Flow
-6,973
1,083
4,113
-4,962
Cash
2,618
10,118
9,007
4,687
Basic Shares
13,547
13,541
14,159
14,573

Earnings Calls

Quarter EPS
2024-10-31
$0.05
2024-07-31
$0.11
2024-04-30
$0.01
2024-01-31
-$0.16